Summary: During the last decade, cDNA cloning has identiˆed various gene families of drug transporters, and pharmacokinetic studies of drugs based on the molecular characteristics of transporters have advanced. We cloned and characterized two organic anion transporters OAT-K1 and OAT-K2 from the rat kidney. The expression of both transporters was limited to the kidney, especially the brush-border membranes of proximal tubules, with an apparent molecular mass of 40 kDa. Using MDCK or LLC-PK1 cells stably expressing OAT-K1, posttranslational cleavage was suggested to aŠect the membrane localization and functional characteristics; 50 kDa with multispeciˆcity in the apical membrane of MDCK cells and 70 kDa with methotrexate speciˆc transport in the basolateral membrane of LLC-PK1 cells. A wide variety of anionic compounds including methotrexate are bidirectionally transported via OAT-K1 and OAT-K2 across the apical membrane in the MDCK-transfectants. The urinary secretion of methotrexate was depressed in 5 W 6 nephrectomized rats in association with the selective loss of OAT-K1 and OAT-K2 expression, and both transporters were suggested to be target molecules for methotrexate-folinic acid rescue. In this review, recent advances in the study of OAT-K1 and OAT-K2 were summarized in comparison with other transporters.
Introduction
A diverse array of organic anions including endogenous substances, xenobiotics and metabolites are excreted from the body into urine and W or bile. The net drug excretion into urine is deˆned basically as the sum of three processes, glomerularˆltration, tubular secretion and reabsorption. Of these, the secretion of anionic drugs in renal tubules is an essentially saturable process, since their vectorial transepithelial transport is mediated by plasma membrane transport proteins. The kidney has developed high-capacity transport systems to prevent urinary loss ofˆltered nutrients such as D-glucose, amino acids, and oligopeptides, as well as inorganic ions, and simultaneously to facilitate tubular secretion of a variety of xenobiotics that escape hepatic extraction processes. [1] [2] [3] [4] [5] It is imperative to obtain molecular biological information about kidney-speciˆc drug transporters for a better understanding of renal tubular secretion and W or reabsorption of drugs. Such information would be of clinical importance for predicting interactions of drugs and W or their metabolites with renal transporters, which may result in competition at a tubular secretion or reabsorption site and be accompanied by signiˆcant adverse eŠects.
The organic anion secretion system is a complicated transport process recognizing a wide variety of substrates at the brush-border and basolateral membranes of the proximal tubule. 6) During the last decade, various gene families of renal transporters including organic ion transporter (OAT W OCT W OCTN, SLC22A), organic anion transporting polypeptide (oatp W OATP, SLC21A), peptide transporter (PEPT, SLC15A) and multidrug resistance associated protein (MRP, ABCC) have been identiˆed. 7) Renal basolateral types of organic anion transporters, rOAT1 and rOAT3, were cloned from the rat kidney and characterized. [8] [9] [10] rOAT1 functions as an organic anion W dicarboxylate exchanger, but rOAT3-mediated [ 3 H]estrone sulfate uptake was not stimulated by outward gradient of p-aminohippuric acid (PAH), A nomenclature of the oatp W OATP gene family based on the recommendations of the Human Gene Nomenclature Committee (http: W W www.gene.ucl.ac.uk W nomenclature) was also postulated. Abbreviations used in thisˆgure are as follows; h, human; r, rat; BL, basolateral membrane; AP, apical (brush-border) membrane; Lv, liver, Cp, coroid plexus; Rt, retina; K, kidney; BBB, blood brain barrier; Lg, lung.
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Satohiro MASUDA unlabeled estrone sulfate or ochratoxin A. 10, 11) These transporters are suggested to mediate the basolateral entry of anionic drugs into the proximal tubular epithelial cells. In contrast, the brush-border type transport system(s), which mediates the secretion of various types of organic anions from cell to lumen, has not been fully characterized. In 1994, a Na ＋ -independent organic anion transporting polypeptide (oatp1) was originally cloned from a rat liver cDNA library and characterized. 12) Because oatp1-related genes were expressed in several tissues including the kidney, thereafter, various transporter proteins belonging to the oatp W OATP gene family were cloned and characterized. [13] [14] [15] The kidneyspeciˆc homologues OAT-K1 and OAT-K2 were isolated in our laboratory using a reverse transcriptasepolymerase chain reaction (RT-PCR) technique. 16, 17) Although rat oatp and human OATP transporters mediate the hepatic uptake of taurocholic acid, dehydroepiandrosterone (DHEA)-sulfate, estradiol-17b-gurucuronide and thyroid hormones, the amino acid identities between them are relatively low. Except rat prostaglandin transporter (PGT) and human PGT, rat oatp transporters do not represent orthologous gene products of human OATPs. However, the pharmacokinetic characteristics of many ionic drugs in rats were similar in humans in terms of membrane transport.
Therefore, the functional characterization of OAT-K1 and OAT-K2 in rat kidney would be useful for further study including the identiˆcation of functional counter gene(s) in humans. This review deals with recent advances in cellular and molecular studies regarding the identiˆcation, characterization and pathophysiological role of renal organic anion transporters, focusing on OAT-K1 and OAT-K2. An insight into their pharmacological and toxicological characteristics is also given in comparison with other transporters.
Structure and tissue distributions of OAT-K1 and OAT-K2
After screening a rat kidney cDNA library, we successfully isolated two cDNAs encoding OAT-K1 and OAT-K2 as homologoues of oatp1 originally isolated from the rat liver. Various transporter cDNAs were subsequently cloned, and the oatp W OATP gene family grew [13] [14] [15] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] (Fig. 1) . OAT-K1 and OAT-K2 showed 72z and 77z amino acid identity with rat oatp1, respectively, and 91z identity with each other (Fig. 2) . Recently, WolŠ and Su 29) revealed 14 spliced variants of OAT-K including our cloned OAT-K1 and OAT-K2 from the rat kidney. The alternative splicing resulted in 14 isoforms with 357¿670 amino acids generated by the variable N-termini and conserved C-termini, whose calculated molecular masses ranged from 39 to 74 kDa, with identities to OAT-K1 ranging from 97 to 53z. However, the functional characteristics of these isoforms except OAT-K1 and OAT-K2 are still unknown. Because at least 55¿60z of human genes have been shown to be products of alternative splicing, the diversity of renal organic anion transporters in mammalians would be enhanced by alternative splicing mechanisms. 30) Northern blotting and RT-PCR showed that the mRNA of OAT-K1 and OAT-K2 was expressed only in the kidney. In addition, RT-PCR analyses with microdissected nephron segments revealed that the OAT-K1 mRNA (876 bp) was expressed in the proximal convoluted tubules (PCT), proximal straight tubules (PST), and outer medullary collecting ducts (OMCD) (Fig. 3Aa) , and the OAT-K2 mRNA in the PCT, PST and cortical collecting ducts (CCD) (Fig. 3Ab) . 17, 31) Partial nucleotide sequencing of the shorter band (¿800 bp) indicated that the product was derived from oatp1 ( Fig. 3Aa) . The rOAT1 and organic cation transporter rOCT1 mRNAs were detected only in the PCT, while the rOCT2 mRNA was visualized widely along the nephron in the PCT, PST, medullary thick ascending limbs and CCD (Fig. 3Ac-e) . 32) These results suggested the physiological signiˆcance of PCT and PST in drug secretion into the urine via various transporters. In addition, these transporters were suggested to act in concert during the vectorial tubular secretion of ionic drugs: the basolateral entry and the luminal secretion W reabsorption of drugs. Although the physiological importance of drug transporters in distal tubules is still unknown, OAT-K1, OAT-K2 and rOCT2 found in the CCD and OMCD may mediate membrane transport of ionic compounds relating to the homeostasis of the renal physiological environment in rats.
Membrane localization of OAT-K1 and OAT-K2 in the kidney
Western blot analysis revealed that an immunoreactive protein with an apparent molecular mass of 40 kDa was expressed preferentially in the renal crude plasma membranes. Because the antibody recognized the conserved amino acid sequences near the COOH terminal of both OAT-K1 and OAT-K2, 31) we assumed that the band represents OAT-K1 and OAT-K2. The apparent molecular mass of 40 kDa was smaller than the calculated value of 74 kDa for OAT-K1 and 59 kDa for OAT-K2 (without potential sugar chains), suggesting proteolytic processing. A similar event was reported in immunoblotting of oatp1 expressed in the rat kidney, and two alternative cleavage sites have been postulated in oatp1. 33) Interestingly, proteolytic cleavage of oatp1 was observed in the kidney but not in the liver, suggesting a diŠerence in the biosynthetic processing of oatp1 between these tissues. Although the two cleaved portions of oatp1 protein in the kidney were reported to be linked by a disulˆde bond after the internal processing, the OAT-K transporter proteins were suggested not to exist as oligomeric forms linked by a disulˆde bond. The molecular mechanism(s) of the posttranslational cleavage site(s) of both OAT-K proteins and oatps in the rat kidney should be studied with additional antibodies recognizing the amino acid sequences near the NH2 terminal of these transporters.
The stably transfected LLC-PK1 cells expressing OAT-K1 (LLC-OAT-K1) showed an enhanced uptake of methotrexate from the basolateral side, but not the apical side (Fig. 4) .
16) Therefore, OAT-K1 was suggested to be localized in the basolateral membranes of LLC-PK1 cells. In contrast, OAT-K1 appeared in the brushborder membranes but not in the basolateral membranes from both the renal cortex and medulla in the rats. 31) In addition, the protein with an apparent molecular mass of 50 kDa in the plasma membrane fractions of MDCK cells stably transfected with the OAT-K1 cDNA (MDCK-OAT-K1), but not control MDCK cells, 34) was smaller than the value of 74 kDa calculated for OAT-K1 16) and that found in the LLC-OAT-K1 cells (70 kDa) (Fig. 4) . Therefore, the proteolytic processing and W or excision of OAT-K1 in renal tubular cells would be retained in the MDCK cells, but not in the LLC-PK 1 cells. Because the apparent Michaelis constant (Km) value of OAT-K1-mediated methotrexate uptake from the apical side in the MDCK-OAT-K1 cells (2 mM) was comparable with that from the basolateral side in the LLC-OAT-K1 cells (1 mM), the methotrexate transport activity via OAT-K1 is conserved in these transfectants, suggesting small type OAT-K1 protein-mediated methotrexate transport in the renal brush-border membranes.
In 1999, F äolsh et al. 35, 36) demonstrated that a m1B protein, which was a subunit of an adaptor protein (AP-1) complex of clathrin coats, was a key factor for accurate basolateral sorting of membrane proteins. LLC-PK1 cells do not express m1B and missort many basolateral membrane proteins to the apical surface. However, MDCK cells with constitutive expression of m1B and the LLC-PK1 cells stably transfected with human m1B cDNA correctly sort basolateral proteins post-endocytically. 37) In contrast, an apical AQP2 water channel was missorted to the basolateral membrane with the vasopressine stimuli in the LLC-PK1 cells, and was constitutively sorted to the apical membrane in the MDCK cells. 38, 39) These results indicate that the apical targeting mechanism for AQP2 is lacked in LLC-PK1 cells, although that is conserved in MDCK cells. Despite the exclusive apical localization of the type IIa Na ＋ -dependent phosphate transporter, NaPi2, in the rat renal proximal tubules, the exogenously expressed NaPi2 proteins were inserted equally per surface ratio into the apical and basolateral membranes in the MDCK monolayers, and no signal of the NaPi2 protein was observed in apical or basolateral membranes in the 
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Satohiro MASUDA NaPi2-transfected Caco-2 monolayers. 40, 41) However, NaPi2 protein was detected at a high intensity in the apical membranes in the LLC-PK1 and OK monolayers transfected with NaPi2.
41) The lack of a speciˆc mechanism for the apical targeting of NaPi2 in MDCK as well as Caco-2 cells was suggested. Therefore, the apical W basal localization of some membrane proteins including OAT-K1, AQP2 and NaPi2 in transfected cultured cells might diŠer from that in vivo, and therefore, a suitable expression system for each transporter should be chosen to collect accurate data of functional characteristics.
Broad substrate spectrum of OAT-K1 and OAT-K2
Although the substrate of OAT-K1 was speciˆcally restricted to folic acid and its derivatives such as methotrexate when the transporter was expressed in the LLC-PK1 cells 16) and Xenopus oocytes, 34) a broad substrate spectrum was revealed in the MDCK transfectants. 42) In addition, OAT-K2 also mediated the transport of various organic compounds in the MDCK transfectant. By proteolytic processing and W or excision, OAT-K1 protein in the MDCK-OAT-K1 cells and in the renal tubular cells may lose some structural obstacle features, which determine the strict substrate recognition in LLC-OAT-K1 cells and in OAT-K1-expressing oocytes. These results suggested that the proteolytic processing was at least a part of the required mechanism(s) to show the broad substrate speciˆcity of OAT-K1 and OAT-K2 as well as the actual membrane localization to the apical side in the rat kidney.
The transported substrate and the kinetic parameters in MDCK-OAT-K1 and MDCK-OAT-K2 are summarized in comparison with those of other rat oatps in Table 1 . OAT-K1 and OAT-K2 had comparable a‹ni-ties for structurally unrelated compounds between 2 and 80 mM. The Km values of these compounds for oatps had a similar range to those of OAT-K1 and OAT-K2.
Oatp1 and oatp2 as well as human OATP-A transported the cationic compound N-(4,-azo-n-pentyl-21)-deoxyajmalinium and rocuronium, and rat oatp2 recognized the electro-neutral compound digoxin as its substrate. 14, 43) In addition, both OAT-K1 and OAT-K2 mediated the uptake of the cationic antiretroviral drug zidovidine. These observations suggest that transporters belonging to the oatp W OATP gene family also transport nonanionic compounds. However, OAT-K1 and OAT-K2 did not transport leukotriene C4 (LTC4) and digoxin, substrates for oatps and oatp2, respectively. In addition, tetraethylammonium and PAH, which are typical substrates for the classical renal organic cation transporters and organic anion transporters, respectively, are not recognized by these transporters. 16, 17, 23) The structural requirement(s) for recognition by these transporters in addition to the electric charge moiety and hydrophobility should be clariˆed in future studies.
By use of the stable transfectant MDCK-OAT-K1, the OAT-K1-mediated methotrexate uptake from the apical side was found to be markedly decreased in the presence of folic acid and its derivatives such as, folinic acid, 5-methyltetrahydrofolic acid and aminopterin with inhibition constant (Ki) values of 14.1 mM, 8.2 mM, 1.2 mM and 0.5 mM, respectively. 44) Moreover, the eOEux of preloaded [ 3 H]methotrexate from MDCK-OAT-K1 cells was stimulated in the presence of the counterdirected transmembrane gradient of these four compounds, suggesting that OAT-K1 acts as an exchanger. Although the oatp1-or oatp2-mediated taurocholic acid uptake was stimulated by intracellular glutathione, 45, 46) the OAT-K1-mediated methotrexate eOEux was not stimulated by the extracellular glutathione and taurocholic acid. Therefore, OAT-K1-mediated transport of methotrexate may be independent of other structurally unrelated anionic compounds and in‰uenced only by the folic acid derivatives.
By comparing the Km and Ki values, the mechanism of substrate recognition by OAT-K1 and OAT-K2 can be discussed ( 3 H]zidovudine uptake by OAT-K1 and OAT-K2 was signiˆcantly inhibited by unlabeled zidovudine, but not by methotrexate, DHEA-3-sulfate, tetraethylammonium, or cimetidine at a concentration of 100 mM. These discrepancies between Km value and Ki values of substrates suggested that OAT-K1 and OAT-K2 have multiple substrate recognition sites. Therefore, the multiple substrate recognition sites in the OAT-K1 and OAT-K2 molecules may minimize the severe drug-drug or drug-endogenous compound interactions via the transporter, reducing adverse eŠects on the body such as elevated plasma concentration or delayed excretion of drugs, toxins, and metabolites.
Role of OAT-K1 and OAT-K2 in the urinary excretion of methotrexate As described above, OAT-K1 and OAT-K2 were suggested to mediate the transport of anionic drugs and metabolites in the brush-border membranes of the renal proximal tubules. Among the transporters belonging to the oatp W OATP gene family, the physiological and pharmacokineic roles of OAT-K1 and OAT-K2 can be discussed based on the renal handling of methotrexate in vivo.
The antifolic acid methotrexate has been widely used in the treatment of acute lymphocytic leukemia at high doses and of rheumatoid arthritis at relatively low doses. [47] [48] [49] Because urinary excretion represents the major route of elimination from the body, high concentrations are achieved in the renal tubules causing nephrotoxicity, a severe problem associated with methotrexate therapy. 50, 51) To reduce the toxicity of methotrexate, folinic acid rescue is used. 48, 52) Folinic acid induces repletion of intracellular reduced folic acids and the resumption of tetrahydrofolic acid-dependent macromolecular synthesis. 47) In addition, treatment with folinic acid accelerates the renal excretion of methotrexate, reducing the duration of exposure. 53) In renal impairment, the dosage regimen of drugs must be modiˆed because renal failure has a variety of in‰uences on pharmacokinetics and pharmacodynamics . 54, 55) Despite a quarter century of clinical experience with methotrexate, the ideal dosage regimen for this drug in renal impairment is not well established. In general, the dose of methotrexate is decreased proportionately to the decrease in creatinine clearance, but unexpected side eŠects such as an excessively increased plasma concentration and nephrotoxicity are often ob- 
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Satohiro MASUDA served. 47, 56) Therefore, animal models of renal disease would help us to examine the role of tubular transporters in the urinary excretion of drugs.
As renal ablation results in proteinuria, functional hypertrophy and progressive kidney disease in the rat, 57) 5 W 6 nephrectomized (NR) rats have been widely used to study the progression of renal damage. There have been various reports concerning the mechanisms of glomerular dysfunction in remnant nephrons. 57, 58) Renal tubule dysfunction has also been reported in chronic renal failure (CRF). Kwon et al. 59) reported that the levels of expression of AQP1, AQP2 and AQP3 were decreased in CRF. In addition, it was reported that there were signiˆcant decreases in total kidney levels of proximal tubular sodium transporters such as the type 3 Na ＋ W H ＋ exchanger (NHE-3) in rats with CRF. 60) The expression of the tubular ATP-driven multispeciˆc organic anion transporter MRP2 was shown to be up-regulated in 5 W 6 NR rat kidneys. 61) Because the morphological tubular damage was not so severe whereas 5 W 6 NR caused marked renal insu‹ciency including glomerular hypertrophy, we selected the rats two weeks after the surgery to avoid the possibility of non-speciˆc eŠects of renal failure on the methotrexate renal handling. The methotrexate pharmacokinetics changed extensively following 5 W 6 NR. 62) There was a marked increase in the plasma methotrexate concentration and a decrease in methotrexate renal clearance, causing a longer exposure to methotrexate. Moreover, the beneˆcial eŠects of folinic acid such as an enhancement of methotrexate secretion in sham-operated rats,``folinic acid rescue'', disappeared in 5 W 6 NR rats (Fig. 5) . 62) As summarized in Table 2 , the expression of the basolateral organic anion transporters rOAT1 and rOAT3 or the apical rMRP2 was maintained at 2 weeks after the 5 W 6 NR. In addition, the clinical concentration of folinic acid (¿10 mM) did not inhibit the rOAT1-mediated methotrexate uptake. In contrast, the mRNA expression levels of OAT-K1 and OAT-K2 were dramatically decreased in the remnant kidneys. Therefore, the depressed levels of tubular OAT-K1 and OAT-K2 would be a speciˆc response to reduced renal mass among the tubular transporters mediating the transport of methotrexate, and were suggested to cause the decreased renal excretion of methotrexate, which results in the longer exposure to methotrexate and ineŠectiveness of folinic acid rescue in 5 W 6 NR rats. Therefore, OAT-K1 and OAT-K2 would play a predominant role in the renal secretion of methotrexate, and be responsible for the beneˆcial eŠects of folinic acid in accelerating the excretion of accumulated methotrexate. Similarˆndings were recently reported in unilaterally nephrectomized rats.
63) The toxic eŠects of a one-month repeated oral dosing of methotrexate were more severe in unilaterally nephrectomized rats than sham-operated rats. It was suggested that these eŠects were caused by the longer exposure to methotrexate in the former because of the decreased renal clearance. These results may be accounted for by assuming the reduced expression levels of OAT-K1 and OAT-K2 in unilaterally nephrectomized rat kidneys. Theseˆndings provide important information regarding the appropriate usage of methotrexate and folinic acid and may be useful guiding principles for adjusting the optimal dosage regimen of these drugs under renal impairment, based on not only the glomerularˆltration rate but also the changes in expression levels of tubular drug transporters under condition of renal insu‹ciency.
As described above, the expression levels of OAT-K1 and OAT-K2 were markedly diminished two weeks after renal ablation as compared to those in the sham-operated kidneys, whereas the protein expression levels of basolateral organic anion transporters rOAT1 and rOAT3 were maintained ( Table 2) . Recently, we have found that the down-regulation of rOCT2 expression in 5 W 6NR rat kidneys was due to the reduced plasma level of testosterone, and the depressed expression level of rOCT2 in the 5 W 6NR rats was ameliorated by supplementary treatment with testosterone. 64) In contrast, its homologue rOCT1 protein level was not changed by 5 W 6 nephrectomy and treatment with testosterone. In that report, the rOCT2 expression level was demonstrated to be a key factor for the cimetidine renal clearance in the male rats. In the same way, the physiological signiˆcance of other transporters localized on the luminal side of proximal tubules was examined. The expression levels of apical rSGLT1, rSGLT2, rPEPT1 and rMRP2 were not signiˆcantly changed by 5 W 6 nephrectomy, whereas the expression of rPEPT2 and the higha‹nity type of H ＋ -coupled glycylsarcosine uptake by the renal brush-border membrane vesicles were up-regulated about 3 fold, suggesting the enhanced reabsorption of peptide mimic drugs during chronic renal failure ( Table 2) . 62, 65) Theseˆndings indicate that the expressional changes of tubular transporters in 5 W 6NR rats provide useful information for understanding their regulation in pathophysiological states. The precise mechanism(s) responsible for the expressional regulation of transporter proteins such as transcription, translation and W or intracellular tra‹cking should be clariˆed in future.
Perspective
Recentˆndings on the molecular aspects of organic anion transporters in the kidney have facilitated studies on mechanisms of drug disposition as well as transporter-mediated drug interactions. The OAT, oatp W OATP and MRP families are suggested to be components of the``organic anion transporter network'' in the proximal tubular cells, and contribute to the renal distribution, tubular secretion and reabsorption of anionic compounds. Molecular information on these transporters such as functional characteristics including substrate speciˆcity, transcriptional regulation, posttranslational modiˆcation, protein-protein interaction, protein turn over rate and genetic variation should be collected to establish an in silico simulation model of renal epitherial cells for predicting the vectorial transcellular transport of pre-marketed anionic drugs.
